to reduce toxicity and improve quality of life in the palliative setting [18], and it is reasonable to assume that most of the side effects among our patients were mild to moderate since the expectation would be that severe side effects would be more likely to be documented in the patient records. However, this is purely conjecture basis on assumptions related to routine practice of patient documentation. One could assume that with IMRT there could in fact be less severe side effects due to reduced radiotherapy doses to adjacent normal structures but we were unable to demonstrate this. More consistent use of symptom assessment scales such as The Edmonton Symptom Assessment System (ESAS) could help in the future to document changes in patients’ symptoms between visits. Better documentation and quantification of toxicities would also be useful to assess side effects. This could be considered for future studies since symptom improvement as well as side effect treatment contribute to patient’s quality of life.

5. Conclusion

Palliative radiation therapy forms a large proportion of the work load of many radiotherapy departments and delivering IG-IMRT using TomoTherapy® provides an efficient alternative to traditional palliative radiotherapy techniques. The ability to scan, plan, and treat patients all on a single unit in a single appointment is very convenient for patients, and this retrospective study suggests that response rates compare vary favourably (over 80% within one month) with those in the published literature with more traditional approaches. There was also no difference in response rates related to the site or symptom being treated or the dose fractionation regimen used. However due to the small sample size and lack of adequate documentation is not possible to make a definitive conclusion regarding the side effects related to this approach.

6. Acknowledgements

Then authors would like to thank the Ottawa Cancer Foundation for financial support of this study and Ms. Betty McAndrew for her administrative assistance.


  1. J. P. Ciezki, S. Komurcu and R. M. Macklis, “Palliative Radiotherapy,” Seminars in Oncology, Vol. 27, No. 1, 2000, pp. 90-93.
  2. D. Hoegler, “Radiotherapy for Palliation of Symptoms in Incurable Cancer,” Current Problems in Cancer, Vol. 21, No. 3, 1997, pp. 129-183. doi:10.1016/S0147-0272(97)80004-9
  3. M. Ashby, “The Role of Radiotherapy in Palliative Care,” Journal of Pain and Symptom Management, Vol. 6, No. 6, 1991, pp. 380-388. doi:10.1016/0885-3924(91)90030-8
  4. G. Stevens and I. Firth, “Clinical Audit in Radiation Oncology: Results from One Centre,” Australasian Radiology, Vol. 40, No. 1, 1996, pp. 47-54. doi:10.1111/j.1440-1673.1996.tb00345.x
  5. M. V. Williams, N. D. James, E. T. Summers, A. Barrett and D. V. Ash, “On Behalf of the Audit Sub-Committee, Faculty of Clinical Oncology and the Royal College of Radiologists National Survey of Radiotherapy Fractionation Practice in 2003,” Clinical Oncology (Royal College of Radiologists), Vol. 18, No. 1, 2006, pp. 3-14. doi:10.1016/j.clon.2005.10.002
  6. R. Andrade, et al., “A Simple and Effective Daily Pain Management Method for Patients Receiving Radiation Therapy for Painful Bone Metastasis,” International Journal of Radiation Oncology*Biology*Physics, Vol. 78, No. 3, 2010, pp. 855-859.
  7. L. Vakeat and T. Boterberg, “Pain Control by Ionizing Radiation of Bone Metastasis,” International Journal of Developmental Biology, Vol. 48, No. 5-6, 2004, pp. 599- 606. doi:10.1387/ijdb.041817lv
  8. M. Van den Beuken-van Everdingen, et al., “Prevalence of Pain in Patients with Cancer: A Systematic Review of the past 40 Years,” Annals of Oncology, Vol. 18, No. 9, 2007, pp. 1437-1449. doi:10.1093/annonc/mdm056
  9. R. Samant and A. C. Gooi, “Radiotherapy Basics for Family Physicians: Potent Tool for Symptom Relief,” Canadian Family Physician, Vol. 51, No. 11, 2005, pp. 1496-1501.
  10. A. Konski, S. Feigenberg and E. Chow, “Palliative Radiation Therapy,” Seminars in Oncology, Vol. 32, No. 2, 2005, pp. 156-164. doi:10.1053/j.seminoncol.2004.11.013
  11. M. MacPherson, et al., “On-Line Rapid Palliation Using Helical Tomotherapy: A Prospective Feasibility Study,” Radiotherapy and Oncology, Vol. 87, No. 1, 2008, pp. 116-118. doi:10.1016/j.radonc.2008.01.017
  12. R. Samant, L. Gerig, L. Montgomery, R. Macrae, et al., “High-Technology Palliative Radiotherapy Using ImageGuided Intensity-Modulated Radiotherapy,” Clinical Oncology (Royal College of Radiologists), Vol. 20, No. 9, 2008, pp. 718-720. doi:10.1016/j.clon.2008.08.002
  13. R. Samant, L. Gerig, L. Montgomery, R. Macrae, et al., “The Emerging Role of IG-IMRT for Palliative Radiotherapy: A Single-Institution Experience,” Current Oncology, Vol. 16, No. 3, 2009, pp. 40-45.
  14. I. Lee, et al., “Early Clinical Experience and Outcome of Helical Tomotherapy for Multiple Metastatic Lesions,” International Journal of Radiation Oncology*Biology* Physics, Vol. 73, No. 5, 2009, pp. 1517-1524.
  15. S. Ryu, et al., “Pain Control by Image-Guided Radiosurgery for Solitary Spinal Metastasis,” Journal of Pain and Symptom Management, Vol. 35, No. 3, 2008, pp. 292-298. doi:10.1016/j.jpainsymman.2007.04.020
  16. J. Sheehan, et al., “Radiosurgery in the Treatment of Spinal Metastases: Tumour Control, Survival, and Quality of Life after Helical Tomotherapy,” Neurosurgery, Vol. 65, No. 6, 2009, pp. 1052-1062. doi:10.1227/01.NEU.0000359315.20268.73
  17. S. Lutz, S. S. Lo, E. Chow, A. Sahgal and P. Hoskin, “Radiotherapy for Metastatic Bone Disease: Current Standards and Future Prospectus,” Expert Review of Anticancer Therapy, Vol. 10, No. 5, 2010, pp. 683-695. doi:10.1586/era.10.32
  18. J. Baisden, et al., “Helical Tomotherapy in the Treatment of Central Nervous System Metastasis,” Neurosurgery Focus, Vol. 22, No. 3, 2007, pp. 1-6. doi:10.3171/foc.2007.22.3.9


*Corresponding author.

Journal Menu >>